Regulatory - REDFILED (Page 3)

Zeta Network Group shareholders approved a package of share capital changes.

ZNB

ZETA NETWORK (ZNB) Shareholders Approve Second 8-for-1 Reverse Split

Holders of Zeta Network Group backed a second eight-for-one consolidation, a capital reduction to $0.0001 par and a rise in authorised capital to $32 million.

Photodynamic therapy is used in dermatology to treat pre-cancerous and cancerous skin lesions.

BFRI

FDA Approves BIOFRONTERA's Ameluz for Superficial Basal Cell Carcinoma

Ameluz with the BF-RhodoLED lamp becomes the first photodynamic therapy cleared in the US to treat a skin cancer, with a launch planned from late 2026.

Cardiff Oncology has amended the license agreement underpinning its lead program.

CRDF

CARDIFF ONCOLOGY Settles Suit With Nerviano, Amends 2017 License

An 8-K discloses a confidential settlement and a rewritten license agreement covering the exclusive worldwide rights Cardiff licensed from Italy's Nerviano Medical Sciences in 2017.

Ameluz gel is used with a red-light lamp to treat skin lesions in a dermatology office.

BFRI

FDA Approves BIOFRONTERA's Ameluz PDT for Superficial Basal Cell Carcinoma

Ameluz combined with the BF-RhodoLED lamp becomes the first photodynamic therapy approved in the US to treat a skin cancer, adding up to 720,000 annual cases to its market.

New Fortress Energy operates liquefied natural gas infrastructure and terminals.

NFE

NEW FORTRESS ENERGY Recapitalizes With 1-for-50 Reverse Split

An amended charter effective September 11, 2026 combines every 50 Class A shares into one, wipes out Class B stock and creates mandatorily convertible preferred.

Karyopharm reached a forbearance agreement with its term loan lenders, noteholders and royalty investors.

KPTI

KARYOPHARM Strikes Forbearance Deal With Lenders and Noteholders

Karyopharm signed a forbearance agreement and limited waiver covering its term loan, both 9.00% convertible note series and its royalty financing.

A freight train on a North American rail network.

CNI

CN Files Midwest Access Conditions in UNION PACIFIC-Norfolk Southern Merger Review

CN told the Surface Transportation Board it will seek trackage rights and yard access in Kansas City, St. Louis and Illinois as a merger remedy.

A driverless robotaxi operating on a city street.

WRD

WERIDE Wins Spain's First National Permit for Level 4 Robotaxis

WeRide, Uber and fleet operator AVOMO received Spain's first national Level 4 autonomous passenger vehicle permit, targeting a commercial Madrid launch by end-2026.

WeRide's GXR autonomous vehicle is set for supervised testing in the Madrid region.

WRD

WERIDE and Uber Win Spain's First National Level 4 Robotaxi Permit

Spain's traffic authority cleared WeRide, Uber and fleet operator AVOMO to prepare a driverless service in Madrid, with commercial rides targeted by end-2026.

Intelligent Bio Solutions is seeking U.S. clearance for a fingerprint-based drug screening system.

INBS

INTELLIGENT BIO SOLUTIONS Files FDA 510(k) for Fingerprint Drug Test

INBS submitted its 510(k) premarket notification for codeine detection with its fingerprint sweat screening system, backed by studies showing 100% specificity.

Iveda founder and chief executive David Ly.

IVDA

IVEDA Wins Second 180-Day Nasdaq Extension on $1 Bid Price

Iveda has until March 1, 2027 to close above $1.00 for ten straight sessions and says a reverse split remains one option.

A quantum computing system of the type built by D-Wave.

QBTS

D-WAVE QUANTUM Hands US Commerce Department an Equity Stake for CHIPS Award

D-Wave agreed to issue common stock to the US Department of Commerce at $14.093 per share as an inducement for a CHIPS Act award signed on September 4, 2026.